Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Elsevier
Milestone influenza publication by Elsevier journal Vaccine
October 29th, 2008
Last month during an influenza conference organized by the European Scientific Working Group on influenza (ESWI), the Elsevier journal Vaccine released a supplement dedicated to influenza vaccines This publication provides a comprehensive, state-of-the-art overview on influenza vaccines and was supported by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Influenza, commonly known as (the) Flu, continues to be a major cause of mortality, and vaccination remains the mainstay of efforts to prevent and control the disease. Flu spreads around the world in seasonal epidemics,...
Source: Vaccine Weekly (2008-10-29)
|
